ESO Lymphoma Course
A

Common "Epigenetic" Somatic Mutations in Lymphoma: CREBBP, EP300, HDAC3, TET2, KMT2D, EZH2

By ESO Lymphoma Course FEATURING Ari Melnick
By ESO Lymphoma Course FEATURING Ari Melnick
29 views
September 12, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Related Content

AUTOPLAY
13:07
Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez
13:56
SOHO 2023 Eleventh Annual Meeting

Follicular Lymphoma Management: What Is the New Order?

Feat. B. Kahl
62:02
UChicago Medicine

New Treatment Strategies in DLBCL

Feat. L. Sehn
16:03
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: The New Algorithm for 2L LBCL

Feat. J. Westin
15:26
Moffitt Cancer Center

R/R DLBCL: Are CAR-Ts Superior to Bispecific Antibodies?

Feat. A. Lazaryan
27:51
Louisville Hematology Highlights

Summary of Recent Advances in Follicular Lymphoma

Feat. S. Gaballa
05:38
GRACE

Epcoritamab in NHL - Incidence and Management of CRS

Feat. T. Phillips
35:28
UNC Lineberger Comprehensive Cancer Center

DLBCL Management: Updates for 2023

Feat. N. Grover
17:11
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Incorporating Novel Agents in Frontline DLBCL

Feat. L. Sehn
16:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Targeted Therapy Updates for Aggressive B-Cell Lymphomas

Feat. D. Landsburg
13:46
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitama…

Feat. J. Westin
10:36
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in…

Feat. R. Merryman
33:48
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: B-Cell Lymphoma

Feat. L. Nastoupil
21:58
MedNews Week

The Evolving 1L DLBCL Landscape: POLARIX, Novel Agents and Future Di…

Feat. M. Matasar
09:32
SOHO 2023 Eleventh Annual Meeting

Upfront Management of DLBCL

Feat. C. Flowers
42:09
University of Colorado Department of Medicine

Immunotherapy in Lymphomas: The Present and the Future

Feat. M. Kamdar
10:17
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Shifting Strategies in R/R DLBCL

Feat. M. Lunning
04:16
GRACE

Mosunetuzumab for R/R Follicular Lymphoma

Feat. T. Phillips
10:06
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 Next Questions: Aggressive B-Cell Lymphoma

Feat. G. Nowakowski
35:27
Louisville Hematology Highlights

Updates on Management of DLBCL

Feat. J. Leonard